Fig. 1.

Patient disposition.^aAll randomized patients who received ≥1 dose of double-blind study medication; ^bAll randomized patients who received ≥1 dose of double-blind study medication and had ≥1 valid post-baseline efficacy assessment; ^cAll patients in the full analysis set who had no major protocol violations